Sanofi (SNY) reported Q1 earnings Thursday of 1.79 euros ($2.04) per share, up from 1.53 euros a year earlier.
Revenue for the quarter ended March 31 was 9.90 billion euros, compared with 8.93 billion euros a year earlier.
Analysts polled by FactSet expected 9.95 billion euros.
The company reaffirmed its 2025 business EPS guidance of a low double-digit percentage growth at current exchange rate. It also maintained sales guidance to grow by a mid-to-high single-digit percentage at current exchange rate. Analysts polled by FactSet expect 44.97 billion euros.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.